The incidence of comorbid diseases in patients diagnosed with fibromyalgia

Yıl 2019, , 131 - 135, 01.06.2019

Harun Düğeroğlu

https://doi.org/10.21601/ortadogutipdergisi.448880

Öz

Aim: The aim of the study was to determine the frequency
of comorbid diseases in patients diagnosed with fibromyalgia by the Physical Therapy
Clinic.

Material and Method: Data of 674 patients diagnosed with fibromyalgia
between January 2013 and May 2018 were retrospectively reviewed. Comorbid disease
data of patients diagnosed with fibromyalgia were analyzed statistically.

Results: 208 (30.8%) of the 674 patients were male and
466 (69.2%) were female. The mean age of the patients was 49.2±10.4 years in males
and 50.4±12.7 years in females. There were at least one comorbid disease in 548
patients (81.3%) and no comorbid disease in 126 (18.6%) patients. The most common
comorbid diseases were cardiovascular diseases in 224 (40.8%) patients and endocrine
diseases in 187 (34.1%) patients.

Conclusion: Fibromyalgia is an increasingly prevalent disease
in recent years. Close monitoring of comorbid disease states of patients diagnosed
with fibromyalgia will be useful in the treatment of fibromyalgia.

Anahtar Kelimeler

Comorbidity, fibromyalgia, incidence, chronic diseases

Fibromiyalji tanısı konulan hastalarda komorbid hastalıkların görülme sıklığı

Öz

Amaç: Çalışmanın amacı, Fizik Tedavi kliniği tarafından
fibromiyalji tanısı konulan hastalarda komorbid hastalıkların sıklığını belirlemeyi
amaçladık.

Gereç ve Yöntem: Çalışmaya Ocak 2013 - Mayıs 2018 tarihleri
arasında fibromiyalji tanısı konulan 674 hastanın verileri retrospektif olarak incelenmiştir.
Fibromiyalji tanısı konulan hastaların komorbid hastalık verileri istatistiksel
olarak analiz edildi.

Bulgular: Çalışmaya alınan 674 hastanın 208 (%30,8)’i
erkek, 466 (%69,2)’ı kadın hastalardı. Hastaların yaş ortalaması, erkeklerde 49,2±10,4
yıl, kadınlarda 50,4±12,7 yıldı. Hastaların 548 (%81,3)’inde en az bir komorbid
hastalık varken, 126 (%18,6) hastada herhangi bir komorbid hastalık yoktu. En sık
görülen komorbid hastalık 224 (%40,8) hasta ile kardiyovasküler hastalıklar, ikinci
sırada 187 (%34,1) hasta ile endokrin hastalıklar yer almaktadır.

Sonuç: Fibromiyalji, son yıllarda sıklığı giderek
artan bir hastalıktır. Fibromiyalji tanısı konulan hastaların, komorbid hastalık
durumlarının yakından takip edilmesi, fibromiyaljinin tedavisinde yararlı olacaktır.

Anahtar Kelimeler

Komorbidite, fibromiyalji, insidans, kronik hastalıklar

Kaynakça

• Bennett RM, Jones J, Turk DC, Russell IJ, Matallana L. An internet survey of 2,596 people with fibromyalgia. BMC Musculoskeletal Disorders 2007; 8:27.
• Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 1995; 38: 19-28.
• Forseth KO, Gran JT, Husby G. A population study of the incidence of fibromyalgia among women aged 26-55 years. Br J Rheumatol 1997; 36: 1318-23.
• White KP, Speechley M, Harth M, Ostbye T. The London Fibromyalgia Epidemiology Study: comparing the demographic and clinical characteristics in 100 random community cases of fibromyalgia versus controls. J Rheumatol 1999; 26: 1577-85.
• Gur A, Cevik R, Nas K, Sarac AJ, Ozen Ş. Quality of life in young fibromyalgia patients and effect of deppression. Aplar J Rheumatol 2006; 9: 70-8.
• Clauw DJ. Fibromyalgia: An overview. Am J Med 2009; 122: 3-13.
• Choy EH, Mease PJ. Key symptom domains to be assessed in fibromyalgia (outcome measures in rheumatoid arthritis clinical trials). Rheum Dis Clin North Am 2009; 35: 329-37.
• Soran N, Altindag Ö, Demirkol A, ve ark. Depression level and relation with clinical parameters in fibromyalgia syndrome. Rheum 2008; 23: 1-4.
• Wolfe F, Hassett AL, Walitt B, Michaud K. Mortality in fibromyalgia: A study of 8,186 patients over thirty?five years. Arthritis Care Res 2011; 63: 94-101.
• Wolfe F, Clauw DJ, Fitzcharles MA, ve ark. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res 2010; 62: 600-10.
• Wolfe F, Smythe HA, Yunus MB, ve ark. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Arthritis Rheum 1990; 33: 160-72.
• İnanıcı F. Fibromiyalji ve Miyofasiyal Ağrı Sendromları. Türkiye Klinikleri J Med Sci 2005; 1: 11-8.
• Al-Allaf A, Mole P, Paterson C, Pullar T. Bone health in patients with fibromyalgia. Rheumatology (Oxford). 2003; 42: 1202-06.
• Baysal Ö, Altay Z, Öner T, Dilek Y, Ünal S, Kaya B. Fibromiyaljili hastalarda venlafaksin ve amitriptilinin karşılaştırılması. Hipokrat Lokomotor 2005; 6:36.
• Karakoç M, Nas K, Çevik R, Erdoğan F, Saraç AY, Coşut S. Fibromiyaljili Hastalarda Amitriptilin ve Lazer Tedavilerinin Etkinliklerinin Karşılaştırılması. Türkiye Fiziksel Tıp ve Rehabilitasyon Derg 2001; 3:47.
• Walitt B, Nahin RL, Katz RS, Bergman MJ, Wolfe F. The prevalence and characteristics of fibromyalgia in the 2012 National Health Interview Survey. PloS One 2015 https://doi.org/10.1371/journal.pone.0138024
• Gerwin RD. Myofascial and visceral pain syndromes: visceralsomatic pain representations. J Musculoskeletal Pain 2002; 10: 165-75.
• Hudson JI, Goldenberg DL, Pope HG, Keck PE, Schlesinger L. Comorbidity of fibromyalgia with medical and psychiatric disorders. Am J Med 1992; 92: 363-7.
• Bilgici A, Akdeniz O, Güz H, Ulusoy H. The Role of Depression and Social Adjustment in Fibromyalgia Syndrome. Turk J Phys Med Rehab 2005; 5: 98-102.
• Hayta E, Doğan ÖT, Doğan SC, ve ark. Clinical features of 100 female patients with fibromyalgia. Cumhuriyet Med J 2010; 32: 74-9.
• Giesecke T, Williams DA, Harris RE, ve ark. Subgrouping of fibromyalgia patients on the basis of pressurepain thresholds and psychological factors. Arthritis Rheumatism 2003; 48: 2916-22.
• Fred-Jimenez RM, Arroyo-Avila M, Mayor AM, Rios G, Vila LM. Clinical Manifestations Associated with Overweight/ Obesity in Puerto Ricans with Fibromyalgia Syndrome. J Obes 2016; 2016:1379289.
• Jackson JL, Mally PG, Tomkins G, ve ark. Treatment of functional gastrointestinal disorders with antidepresant medications: a metaanalysis. Am J Med 2000; 108: 65-72.
• Korszun A, Young EA, Engleberg NC, ve ark. Follicular phase hypothalamic-pituitary-gonadal axis function in women with fibromyalgia and chronic fatigue syndrome. J Rheumatol 2000; 27: 1526-30.
• Okifuji A, Turk DC. Sex hormones and pain in regularly menstruating women with fibromyalgia syndrome. J Pain 2006; 7: 851-9.
• Clauw DJ, Katz P. The overlap between fibromyalgia and inflammatory Rheum disease: when and why does it occur? J Clin Rheumatol 1995;1:335-42.
• Arnold LM, Clauw DJ, McCarberg BH. Fibro Collaborative. Improving the recognition and diagnosis of fibromyalgia. Mayo Clin Proc 2011; 86: 457-64.